This inventor holds 3 USPTO granted patents. Top assignees: Alza Corporation, University of Pennsylvania. Active years: 1986-1993.
Location History:
- Palo Alto, CA (US) (1986)
- Philadelphia, PA (US) (1991 - 1993)
Company Filing History:
Years Active: 1986-1993
Title: Victor Goetz: Innovator in Pharmaceutical Compositions
Introduction
Victor Goetz is a notable inventor based in Philadelphia, PA (US), recognized for his contributions to the field of pharmaceutical compositions. He holds a total of 3 patents, showcasing his innovative approach to reducing the abuse potential of certain substances while maintaining their therapeutic effects.
Latest Patents
One of Goetz's latest patents is focused on an abusable substance dosage form that has a reduced potential for abuse. This invention includes compositions and dosage forms for administering abusable substances, which are designed to minimize abuse without compromising their beneficial effects. The topical compositions are formulated to be applied to the skin or mucosa, containing the abusable substance in a permeable form, along with an antagonist that is present in an abuse-negating amount. This innovative approach allows for the therapeutic use of substances like fentanyl while reducing the potential for misuse. Another significant patent involves a method and apparatus for conducting chromatographic separations using silica-coated, magnetically susceptible particles, enhancing the efficiency of multi-component system separations.
Career Highlights
Victor Goetz has worked with prominent organizations such as Alza Corporation and the University of Pennsylvania. His experience in these institutions has contributed to his expertise in developing advanced pharmaceutical technologies.
Collaborations
Goetz has collaborated with notable individuals in his field, including Eun Soo Lee and Robert M. Gale. Their combined efforts have furthered the development of innovative solutions in pharmaceutical compositions.
Conclusion
Victor Goetz's work exemplifies the intersection of innovation and therapeutic application in the pharmaceutical industry. His patents reflect a commitment to enhancing drug safety and efficacy, making significant strides in the field.